This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Shizuoka Prefecture. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Keiichi Ohshima: Innovator in Cancer Diagnosis
Introduction
Keiichi Ohshima is a notable inventor based in Sunto-gun, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of certain types of cancer. His innovative work has the potential to improve patient outcomes through early diagnosis.
Latest Patents
Ohshima holds a patent for a biomarker that aids in the diagnosis of extrahepatic bile duct carcinoma, intrahepatic bile duct carcinoma, or gallbladder carcinoma. The patent describes a method for collecting highly accurate diagnostic data. This method involves detecting the concentration of CEACAM1 in a blood sample. If the concentration is higher than that in a non-carcinoma control subject, it indicates a high possibility of cancer presence.
Career Highlights
Throughout his career, Keiichi Ohshima has worked with various organizations, including Shizuoka Prefecture and Shizuoka Prefectural University Corporation. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Ohshima has collaborated with notable colleagues such as Tohru Mochizuki and Keiichi Hatakeyama. Their joint efforts have further advanced the research and development of diagnostic methods in oncology.
Conclusion
Keiichi Ohshima's contributions to cancer diagnosis through his innovative patent highlight the importance of early detection in improving patient care. His work continues to inspire advancements in medical technology and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile